<DOC>
	<DOCNO>NCT00195377</DOCNO>
	<brief_summary>The purpose study assess safety etanercept patient rheumatoid arthritis ( RA ) , juvenile idiopathic arthritis ( JIA ) psoriatic arthritis ( PsA ) Spain</brief_summary>
	<brief_title>Study Evaluating Etanercept Patients With Rheumatoid Arthritis ( RA ) , Juvenile Idiopathic Arthritis ( JIA ) , Psoriatic Arthritis ( PsA ) Spain</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Juvenile</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Arthritis , Psoriatic</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>RA PsA DMARDs/antiTNF antibodies/anti IL1 insufficient inappropriate Children 4 17 year old JIA polyarticular Clinically significant abnormal screening lab value Patients plan undergo elective surgery study period . Other current autoimmune connective tissue disease</criteria>
	<gender>All</gender>
	<minimum_age>4 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2009</verification_date>
</DOC>